Patents for Humanity Program Improvement Act of 2013

Patent reform H.R. 3309 S. 1013, S. 1612, S. 866, S. 712

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 22, Foreign Counterfeit Merchandise Prevention Act (entire bill)* H.R. 845, Saving High-Tech Innovators from Egregious Legal Disputes (SHIELD) Act (entire bill)* H.R. 1663, Promoting Automotive Repair. Trade and Sales (PARTS) Act (entire bill)* S. 780, Promoting Automotive Repair. Trade and Sales (PARTS) Act (entire bill)* H.R. 2024, the End Anonymous Patents Act (entire bill)* H.R. 2236, the Promoting Startup Innovation Act (entire bill)* H.R. 2582, the PATENT Jobs Act (entire bill)* S. 214, Prohibiting the delay of generic drugs into the market (entire bill)* S. 662, Trade Facilitation and Trade Enforcement Reauthorization Act of 2013 (IP-related provisions)* S. 866, To Make Improvements to Transitional Program for Covered Business Method Patents (entire bill)* S. 1013 Patent Abuse Reduction Act of 2013 (entire bill).* S. 712, Patents for Humanity Program Improvement Act of 2013 (entire bill)* S. 1478 PACES Act (entire bill)* H.R. 2766, Stopping the Offensive Use of Patents Act (entire bill)* H.R. 2639, Patent Litigation and Innovation Act of 2013 (entire bill)* H.R. 2466, Private Right of Action Against Theft of Trade Secrets Act of 2013 (entire bill)* H.R. 3309, the Innovation Act (entire bill) H.R. 3349, Innovation Protection Act (entire bill)* S. 1720, Patent Transparency and Improvements Act (entire bill) S. 1612, Patent Litigation Integrity Act of 2013 (entire bill) H.R. 3219, Free Market Royalty Act (entire bill)* H.R. 3713, to provide for the registration of marks consisting of a flag, coat of arms, or other insignia of the United States, or any State or local government (entire bill)* S. 1770, Future of American Innovation and Research (FAIR) (entire bill)* S. 1816, to provide for the registration of marks consisting of a flag, coat of arms, or other insignia of the United States, or any State or local government (entire bill)* S. 2146, Patent Fee Integrity Act (entire bill)* S. 2049, Transparency in Assertion of Patents Act (entire bill)* H.R. 4079 Songwriter Equity Act (entire bill)* S. 2321 Songwriter Equity Act (entire bill)* H.R. 4103, American Royalties Too Act (entire bill)* S. 2045, American Royalties Too Act (entire bill)* H.R. 4287, Independent Innovator and Repurposing Act (entire bill)* S. 2150, Independent Innovator and Repurposing Act (entire bill)* S. 2267, the Defend Trade Secrets Act (entire bill) H.R. ____, Targeting Rogue and Opaque Letters Act (entire bill) H.R. 5036, Satellite Television Access Reauthorization Act (entire bill) S. 2454, Satellite Television Access Reauthorization Act (entire bill) H.R. 3540, the Demand Letter Transparency Act of 2013 (entire bill)* H.R. 4763, Trade Protection Not Troll Protection Act (entire bill)* H.R. 4772, RESPECT Act (entire bill) H.R. 5108, Regarding the USPTO Law School Clinic Certification Program (entire bill) H.R. 5233, Trade Secrets Protection Act of 2014 (entire bill) H.R. 5586 You Own Devices Act (YODA)* H.R. 4660, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2015 S. 2437, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2015 H.R. 4487, Legislative Branch Appropriations Act, 2015 H.J. Res 124, Continuing Appropriations Resolution, 2015 H.R. 83, FY2015 Omnibus; Consolidated and Further Continuing Appropriations Act (IP-related provisions only) Issues related to USPTO Director and IPEC Nominations Issues related to USPTO PTAB Proceedings

Patent reform H.R. 3309 S. 1013, S. 1612, S. 866, S. 712

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Patent reform H.R. 3309 S. 1013, S. 1612, S. 866, S. 712

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Patent reform H.R. 3309 S. 1013, S. 1612, S. 866, S. 712

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Patent reform H.R. 3309 S. 1013, S. 1612, S. 866, S. 712

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Innovation/Competitiveness; ICANN Global Top Level Domains; HR 3309 Innovation Act / S.1702 Patent Transparency Act; S.2667 Defend Trade Secrets Act of 2014; S.712 Patents for Humanity Program Improvement Act of 2013

Client expense: $1,242,788 · Firm income: Not reported

Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

H.R. 845, Saving High-Tech Innovators from Egregious Legal Disputes Act of 2013 (the SHIELD Act): Provisions related to patent litigation H.R. 2024, End Anonymous Patents Act: Patent owner information provisions H.R. 2582, PATENT Jobs Act: Provisions related to patent user fees H.R. 2639, Patent Litigation and Innovation Act: Patent litigation provisions H.R. 2766, STOP Act: Provisions related to business method patents H.R. 2985, Combination Drug Development Incentive Act of 2013: Provisions related to exclusivity H.R. 3116, MODDERN Cures Act of 2013: Provisions related to exclusivity H.R. 3309, Innovation Act: Provisions related to patent litigation reform H.R. 3349, Innovation Protection Act: PTO Fee Diversion H.R. 3540, Demand Letter Transparency Act: Provisions related to patent demand letters H.R. 3709, Protecting Consumer Access to Generic Drugs: Provisions related to patent settlements H.R. 4287, Independent Innovator and Repurposing Act: Provisions related to patent term restoration H.R. 4763, Trade Protection not Troll Protection Act: Patent and trade provisions H.R. 5233, Trade Secrets Protection Act of 2014: Provisions related to trade secrets H.R. 5750, Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2014: Provisions related to targeted IP incentives for new indications for rare diseases or conditions S. 214, Preserve Access to Affordable Generics Act: Provisions related to patent settlements S. 504, Fair and Immediate Release of Generic Drugs Act: Provisions related to patent settlements S. 627, Medical Innovation Prize Fund Act: Medical prize provisions S. 712, Patents for Humanity Program Improvement Act of 2013: Transferability of PTO vouchers provisions S. 866, Patent Quality Improvement Act of 2013: Business methods patents provisions S. 1013, Patent Abuse Reduction Act of 2013: Patent litigation provisions S. 1612, Patent Litigation Integrity Act: Patent litigation provisions including bonding S. 1720, Patent Transparency and Improvements Act: Patent litigation provisions S. 2049, Transparency in Assertion of Patents Act: Provisions related to patent demand letters S. 2150, Independent Innovator and Repurposing Act: Provisions related to patent term restoration S. 2196, Patent Fee Integrity Act: Patent fee diversion prohibition S. 2267, Defend Trade Secrets Act of 2014: Provisions related to trade secrets S. 3004, Dormant Therapies Act of 2014: Provisions related to incentives to develop biopharmaceutical products Biopharmaceutical innovation and patent policy issues Biologics data protection issues Draft legislation on demand letters, including Targeting Rogue and Opaque Letters (TROL) Act Issues related to biopharmaceutical economic incentives and intellectual property

- Issues related to patent reform. - S 712, "Patents for Humanity Program Improvement Act of 2013", regarding all provisions. - "Targeting Rogue Opaque Letters Act of 2014", regarding all provisons (no bill number).

Client expense: $1,400,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)

H.R. 22, Foreign Counterfeit Merchandise Prevention Act (entire bill)* H.R. 845, Saving High-Tech Innovators from Egregious Legal Disputes (SHIELD) Act (entire bill)* H.R. 1663, Promoting Automotive Repair. Trade and Sales (PARTS) Act (entire bill)* S. 780, Promoting Automotive Repair. Trade and Sales (PARTS) Act (entire bill)*H.R. 2024, the End Anonymous Patents Act (entire bill)* H.R. 2236, the Promoting Startup Innovation Act (entire bill)* H.R. 2582, the PATENT Jobs Act (entire bill)* S. 214, Prohibiting the delay of generic drugs into the market (entire bill)* S. 662, Trade Facilitation and Trade Enforcement Reauthorization Act of 2013 (IP-related provisions)* S. 866, To Make Improvements to Transitional Program for Covered Business Method Patents (entire bill)* S. 1013 Patent Abuse Reduction Act of 2013 (entire bill).* S. 712, Patents for Humanity Program Improvement Act of 2013 (entire bill)* S. 1478 PACES Act (entire bill)* H.R. 2766, Stopping the Offensive Use of Patents Act (entire bill)* H.R. 2639, Patent Litigation and Innovation Act of 2013 (entire bill)* H.R. 2466, Private Right of Action Against Theft of Trade Secrets Act of 2013 (entire bill)* H.R. 3309, the Innovation Act (entire bill) H.R. 3349, Innovation Protection Act (entire bill)* S. 1720, Patent Transparency and Improvements Act (entire bill) S. 1612, Patent Litigation Integrity Act of 2013 (entire bill) H.R. 3219, Free Markey Royalty Act (entire bill)* H.R. 3713, to provide for the registration of marks consisting of a flag, coat of arms, or other insignia of the United States, or any State or local government (entire bill)* S. 1770, Future of American Innovation and Research (FAIR) (entire bill)* S. 1816, to provide for the registration of marks consisting of a flag, coat of arms, or other insignia of the United States, or any State or local government (entire bill)* S. 2146, Patent Fee Integrity Act (entire bill)* S. 2049, Transparency in Assertion of Patents Act (entire bill)* H.R. 4079 Songwriter Equity Act (entire bill)* S. 2321 Songwriter Equity Act (entire bill)* H.R. 4103, American Royalties Too Act (entire bill)* S. 2045, American Royalties Too Act (entire bill)* H.R. 4287, Independent Innovator and Repurposing Act (entire bill)* S. 2150, Independent Innovator and Repurposing Act (entire bill)* S. 2267, the Defend Trade Secrets Act (entire bill) H.R. ____, Targeting Rogue and Opaque Letters Act (entire bill) H.R. 1123, Unlocking Consumer Choice and Wireless Competition Act (entire bill) S. 517, Unlocking Consumer Choice and Wireless Competition Act (entire bill) H.R. 5036, Satellite Television Access Reauthorization Act (entire bill) S. 2454, Satellite Television Access Reauthorization Act (entire bill) H.R. 3540, the Demand Letter Transparency Act of 2013 (entire bill)* H.R. 4763, Trade Protection Not Troll Protection Act (entire bill) H.R. 4772, RESPECT Act (entire bill) H.R. 5108, Regarding the USPTO Law School Clinic Certification Program (entire bill) H.R. 5233, Trade Secrets Protection Act of 2014 (entire bill) H.R. 5586 You Own Devices Act (YODA) H.R. 4660, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2015 S. 2437, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2015 H.R. 4487, Legislative Branch Appropriations Act, 2015 H.J. Res 124, Continuing Appropriations Resolution, 2015

Patenting of Humanitarian Technologies S. 712: Patents for Humanity Program Improvement Act of 2013Patent Reform H.R. 3309: Innovation Act of 2013 S. 1013: Patent Abuse Reduction Act of 2013 S. 1720: Patent Transparency and Improvements Act of 2013 S. 866: Patent Quality Improvement Act of 2013 Targeting Rogue and Opaque Letters (TROL) Act of 2014 (Discussion Draft) FTC Regulation of Patent Demand Letters (Senate Commerce Committee Discussion Draft) Intellectual Property International Enforcement Compulsory Licensing India Issues TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Transatlantic Trade and Investment Partnership Intellectual Property Issues Patenting of Biological Inventions

Client expense: $2,090,000 · Firm income: Not reported

H.R. 845, Saving High-Tech Innovators from Egregious Legal Disputes Act of 2013 (the SHIELD Act): Provisions related to patent litigation H.R. 2024, End Anonymous Patents Act: Patent owner information provisions H.R. 2582, PATENT Jobs Act: Provisions related to patent user fees H.R. 2605, Manufacturing Innovation in America Act of 2013: Provisions related to patent tax boxes H.R. 2639, Patent Litigation and Innovation Act: Patent litigation proposals H.R. 2766, STOP Act: Provisions related to business method patents H.R. 2985, Combination Drug Development Incentive Act of 2013: Provisions related to exclusivity H.R. 3116, MODDERN Cures Act of 2013: Provisions related to exclusivity H.R. 3309, Innovation Act: Provisions related to patent litigation reform H.R. 3349, Innovation Protection Act: PTO Fee Diversion H.R. 3540, Demand Letter Transparency Act: Provisions related to patent demand letters H.R. 3709, Protecting Consumer Access to Generic Drugs: Provisions related to patent settlements H,R, 4287, Independent Innovator and Repurposing Act: Provisions related to patent term restoration H.R. 4763, Trade Protection not Troll Protection Act: Patent and trade provisions H.R. 5233, Trade Secrets Protection Act of 2014: Provisions related to trade secrets S. 214, Preserve Access to Affordable Generics Act: Provisions related to patent settlements S. 504, Fair and Immediate Release of Generic Drugs Act: Provisions related to patent settlements S. 626, Prize Fund for HIV/AIDS Act: Medical prize provisions S. 627, Medical Innovation Prize Fund Act: Medical prize provisions S. 712, Patents for Humanity Program Improvement Act of 2013: Transferability of PTO vouchers provisions S. 866, Patent Quality Improvement Act of 2013: Business methods patents provisions S. 1013, Patent Abuse Reduction Act of 2013: Patent litigation provisions S. 1612, Patent Litigation Integrity Act: Patent litigation provisions including bonding S. 1720, Patent Transparency and Improvements Act S, 2049, Transparency in Assertion of Patents Act: Provisions related to patent demand letters S.2150, Independent Innovator and Repurposing Act: Provisions related to patent term restoration S. 2196, Patent Fee Integrity Act: Patent fee diversion prohibition S. 2267, Defend Trade Secrets Act of 2014: Provisions related to trade secrets Biopharmaceutical innovation policy issues Biologics data protection issues Draft legislation on demand letters, including Targeting Rogue and Opaque Letters (TROL) Act Issues related to biopharmaceutical economic incentives and intellectual property

- Issues related to patent reform. - S 712, "Patents for Humanity Program Improvement Act of 2013", regarding all provisions. - "Targeting Rogue Opaque Letters Act of 2014", regarding all provisons (no bill number).

Client expense: $1,350,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)

Patent reform H.R. 3309 S. 1013, S. 1612, S. 866, S. 712

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Patent reform H.R. 3309 S. 1013, S. 1612, S. 866, S. 712

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Patent reform H.R. 3309 S. 1013, S. 1612, S. 866, S. 712

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Patent reform H.R. 3309 S. 1013, S. 1612, S. 866, S. 712

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

S. 712, Patents for Humanity Act.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

S. 712, Patents for Humanity Act.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

H.R. 22, Foreign Counterfeit Merchandise Prevention Act (entire bill) H.R. 845, Saving High-Tech Innovators from Egregious Legal Disputes (SHIELD) Act (entire bill)* H.R. 1663, Promoting Automotive Repair. Trade and Sales (PARTS) Act (entire bill)* S. 780, Promoting Automotive Repair. Trade and Sales (PARTS) Act (entire bill)*H.R. 2024, the End Anonymous Patents Act (entire bill)* H.R. 2236, the Promoting Startup Innovation Act (entire bill)* H.R. 2582, the PATENT Jobs Act (entire bill)* S. 214, Prohibiting the delay of generic drugs into the market (entire bill)* S. 662, Trade Facilitation and Trade Enforcement Reauthorization Act of 2013 (IP-related provisions)* S. 866, To Make Improvements to Transitional Program for Covered Business Method Patents (entire bill) S. 1013 Patent Abuse Reduction Act of 2013 (entire bill). S. 712, Patents for Humanity Program Improvement Act of 2013 (entire bill)* S. 1478 PACES Act (entire bill) H.R. 2766, Stopping the Offensive Use of Patents Act (entire bill)* H.R. 2639, Patent Litigation and Innovation Act of 2013 (entire bill)* H.R. 2466, Private Right of Action Against Theft of Trade Secrets Act of 2013 (entire bill) H.R. 3309, the Innovation Act (entire bill) H.R. 3349, Innovation Protection Act (entire bill)* S. 1720, Patent Transparency and Improvements Act (entire bill) S. 1612, Patent Litigation Integrity Act of 2013 (entire bill) H.R. 3713, to provide for the registration of marks consisting of a flag, coat of arms, or other insignia of the United States, or any State or local government (entire bill) S. 1770, Future of American Innovation and Research (FAIR) (entire bill)* S. 1816, to provide for the registration of marks consisting of a flag, coat of arms, or other insignia of the United States, or any State or local government (entire bill) S. 2146, Patent Fee Integrity Act (entire bill) S. 2049, Transparency in Assertion of Patents Act (entire bill) H.R. 4103, American Royalties Too Act (entire bill) S. 2045, American Royalties Too Act (entire bill) H.R. 4287, Independent Innovator and Repurposing Act (entire bill) S. 2150, Independent Innovator and Repurposing Act (entire bill) S. 2267, the Defend Trade Secrets Act (entire bill) H.R. 1123, Unlocking Consumer Choice and Wireless Competition Act (entire bill) S. 517, Unlocking Consumer Choice and Wireless Competition Act (entire bill)

H.R. 22, Foreign Counterfeit Merchandise Prevention Act: Provisions related to counterfeiting H.R. 845, Saving High-Tech Innovators from Egregious Legal Disputes Act of 2013 (the SHIELD Act): Provisions related to patent litigation H.R. 2024, End Anonymous Patents Act: Patent owner information provisionsH.R. 2582, PATENT Jobs Act: Provisions related to patent user fees H.R. 2605, Manufacturing Innovation in America Act of 2013: Provisions related to patent tax boxes H.R. 2639, Patent Litigation and Innovation Act: Patent litigation proposals H.R. 2766, STOP Act: Provisions related to business method patents H.R. 2985, Combination Drug Development Incentive Act of 2013: Provisions related to exclusivity H.R. 3116, MODDERN Cures Act of 2013: Provisions related to exclusivity H.R. 3309, Innovation Act: Provisions related to patent litigation reform H.R. 3349, Innovation Protection Act: PTO Fee Diversion H.R. 3540, Demand Letter Transparency Act: Provisions related to patent demand letters H.R. 3709, Protecting Consumer Access to Generic Drugs: Provisions related to patent settlements H,R, 4287, Independent Innovator and Repurposing Act: Provisions related to patent term restoration H.R. 4763, Trade Protection not Troll Protection Act: Patent and trade provisions S. 214, Preserve Access to Affordable Generics Act: Provisions related to patent settlements S. 504, Fair and Immediate Release of Generic Drugs Act: Provisions related to patent settlements S. 626, Prize Fund for HIV/AIDS Act: Medical prize provisions S. 627, Medical Innovation Prize Fund Act: Medical prize provisions S. 712, Patents for Humanity Program Improvement Act of 2013: Transferability of PTO vouchers provisions S. 866, Patent Quality Improvement Act of 2013: Business methods patents provisions S. 1013, Patent Abuse Reduction Act of 2013: Patent litigation provisions S. 1612, Patent Litigation Integrity Act: Patent litigation provisions including bonding S. 1720, Patent Transparency and Improvements Act S, 2049, Transparency in Assertion of Patents Act: Provisions related to patent demand letters S.2150, Independent Innovator and Repurposing Act: Provisions related to patent term restoration S. 2196, Patent Fee Integrity Act: Patent fee diversion prohibition Biopharmaceutical innovation policy issues Biologics data protection issues Draft legislation on trade secret issues Draft legislation on demand letters Issues related to biopharmaceutical economic incentives and intellectual property

- Issues related to patent reform. - S 712, "Patents for Humanity Program Improvement Act of 2013", regarding all provisions. - "Targeting Rogue Opaque Letters Act of 2014", regarding all provisons (no bill number).

Client expense: $1,060,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Patent reform H.R. 3309 S. 1013, S. 1612, S. 866, S. 712

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Patent reform H.R. 3309 S. 1013, S. 1612, S. 866, S. 712

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Patent reform H.R. 3309 S. 1013, S. 1612, S. 866, S. 712

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Patent reform H.R. 3309 S. 1013, S. 1612, S. 866, S. 712

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 22, Foreign Counterfeit Merchandise Prevention Act: Provisions related to counterfeiting H.R. 845, Saving High-Tech Innovators from Egregious Legal Disputes Act of 2013 (the SHIELD Act): Provisions related to patent litigation H.R. 2024, End Anonymous Patents Act: Patent owner information provisionsH.R. 2582, PATENT Jobs Act: Provisions related to patent user fees H.R. 2605, Manufacturing Innovation in America Act of 2013: Provisions related to patent tax boxes H.R. 2639, Patent Litigation and Innovation Act: Patent litigation proposals H.R. 2766, STOP Act: Provisions related to business method patents H.R. 2985, Combination Drug Development Incentive Act of 2013 H.R. 3116, MODDERN Cures Act of 2013 H.R. 3309, Innovation Act: Provisions related to patent litigation reform H.R. 3349, Innovation Protection Act: PTO Fee Diversion H.R. 3540, Demand Letter Transparency Act of 2013: Provisions related to patent demand letters H.R. 3709, Protecting Consumer Access to Generic Drugs Act of 2013: Provisions related to patent settlements H.R. 4287, Independent Innovator and Repurposing Act: Provisions related to patent term restoration S. 214, Preserve Access to Affordable Generics Act: Provisions related to patent settlements S. 504, Fair and Immediate Release of Generic Drugs Act: Provisions related to patent settlements S. 626, Prize Fund for HIV/AIDS Act: Medical prize provisions S. 627, Medical Innovation Prize Fund Act: Medical prize provisions S. 712, Patents for Humanity Program Improvement Act of 2013: Transferability of PTO vouchers provisions S. 866, Patent Quality Improvement Act of 2013: Business methods patents provisions S. 1013, Patent Abuse Reduction Act of 2013: Patent litigation provisions S. 1612, Patent Litigation Integrity Act of 2013: Patent litigation provisions including bonding S. 1720, Patent Transparency and Improvements Act of 2013: Provisions related to patent litigation, demand letters and the patent system S, 2049, Transparency in Assertion of Patents Act: Provisions related to patent demand letters S. 2150, Independent Innovator and Repurposing Act: Provisions related to patent term restoration S. 2146, Patent Fee Integrity Act: Patent fee diversion prohibition Biopharmaceutical innovation policy issues Biologics data protection issues Draft legislation on trade secret issues

- Issues related to patent reform. - S 712, "Patents for Humanity Program Improvement Act of 2013", regarding all provisions.

Client expense: $2,110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Patent reform H.R. 3309 S. 1013, S. 1612, S. 866, S. 712

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Patent reform H.R. 3309 S. 1013, S. 1612, S. 866, S. 712

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Patent reform H.R. 3309 S. 1013, S. 1612, S. 866, S. 712

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Patent reform H.R. 3309 S. 1013, S. 1612, S. 866, S. 712

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 22, Foreign Counterfeit Merchandise Prevention Act: Provisions related to counterfeiting H.R. 845, Saving High-Tech Innovators from Egregious Legal Disputes Act of 2013 (the SHIELD Act): Provisions related to patent litigation H.R. 2024, End Anonymous Patents Act: Patent owner information provisionsH.R. 2582, PATENT Jobs Act: Provisions related to patent user fees H.R. 2605, Manufacturing Innovation in America Act of 2013: Provisions related to patent tax boxes H.R. 2639, Patent Litigation and Innovation Act: Patent litigation proposals H.R. 2766, STOP Act: Provisions related to business method patents H.R. 2985, Combination Drug Development Incentive Act of 2013: Provisions related to exclusivity for combination drugs H.R. 3116, MODDERN Cures Act of 2013: Provisions related to diagnostics and exclusivity H.R. 3309, Innovation Act: Provisions related to patent litigation reform H.R. 3349, Innovation Protection Act: PTO Fee Diversion H.R. 3540, Demand Letter Transparency Act: Provisions related to patent demand letters H.R. 3709, Protecting Consumer Access to Generic Drugs: Provisions related to patent settlements S. 214, Preserve Access to Affordable Generics Act: Provisions related to patent settlements S. 504, Fair and Immediate Release of Generic Drugs Act: Provisions related to patent settlements S. 626, Prize Fund for HIV/AIDS Act: Medical prize provisions S. 627, Medical Innovation Prize Fund Act: Medical prize provisions S. 712, Patents for Humanity Program Improvement Act of 2013: Transferability of PTO vouchers provisions S. 866, Patent Quality Improvement Act of 2013: Business methods patents provisions S. 1013, Patent Abuse Reduction Act of 2013: Patent litigation provisions S. 1612, Patent Litigation Integrity Act: Patent litigation provisions including bonding S. 1720, Patent Transparency and Improvements Act of 2013: Provisions related to patent litigation and other reforms Biopharmaceutical innovation policy issues Biologics data protection issues Draft legislation on trade secret issues

"H.R. 22, Foreign Counterfeit Merchandise Prevention Act (entire bill) "H.R. 845, Saving High-Tech Innovators from Egregious Legal Disputes (SHIELD) Act (entire bill) "H.R. 1663, Promoting Automotive Repair. Trade and Sales (PARTS) Act (entire bill) "S. 780, Promoting Automotive Repair. Trade and Sales (PARTS) Act (entire bill)H.R. 2024, the End Anonymous Patents Act (entire bill) H.R. 2236, the Promoting Startup Innovation Act (entire bill) H.R. 2582, the PATENT Jobs Act (entire bill) S. 214, Prohibiting the delay of generic drugs into the market (entire bill) S. 662, Trade Facilitation and Trade Enforcement Reauthorization Act of 2013 (IP-related provisions) S. 866, To Make Improvements to Transitional Program for Covered Business Method Patents (entire bill) S. 1013 Patent Abuse Reduction Act of 2013 (entire bill). S. 712, Patents for Humanity Program Improvement Act of 2013 (entire bill) S. 1478 PACES Act (entire bill) H.R. 2766, Stopping the Offensive Use of Patents Act (entire bill) H.R. 2639, Patent Litigation and Innovation Act of 2013 (entire bill) H.R. 2466, Private Right of Action Against Theft of Trade Secrets Act of 2013 (entire bill) H.R. 3309, the Innovation Act (entire bill) H.R. 3349, Innovation Protection Act (entire bill) S. 1720, Patent Transparency and Improvements Act S. 1612, Patent Litigation Integrity Act of 2013 (entire bill) H.R. 3713, to provide for the registration of marks consisting of a flag, coat of arms, or other insignia of the United States, or any State or local government (entire bill) S. 1770, Future of American Innovation and Research (FAIR) (entire bill) S. 1816, to provide for the registration of marks consisting of a flag, coat of arms, or other insignia of the United States, or any State or local government (entire bill) Issues related to possible trade secret legislation

H.R. 22, Foreign Counterfeit Merchandise Prevention Act (entire bill) H.R. 845, Saving High-Tech Innovators from Egregious Legal Disputes (SHIELD) Act (entire bill) H.R. 1663, Promoting Automotive Repair. Trade and Sales (PARTS) Act (entire bill) S. 780, Promoting Automotive Repair. Trade and Sales (PARTS) Act (entire bill)H.R. 2024, the End Anonymous Patents Act (entire bill) H.R. 2236, the Promoting Startup Innovation Act (entire bill) H.R. 2582, the PATENT Jobs Act (entire bill) S. 214, Prohibiting the delay of generic drugs into the market (entire bill) S. 662, Trade Facilitation and Trade Enforcement Reauthorization Act of 2013 (IP-related provisions) S. 866, To Make Improvements to Transitional Program for Covered Business Method Patents (entire bill) S. 1013 Patent Abuse Reduction Act of 2013 (entire bill). S. 712, Patents for Humanity Program Improvement Act of 2013 (entire bill) S. 1478 PACES Act (entire bill) H.R. 2766, Stopping the Offensive Use of Patents Act (entire bill) H.R. 2639, Patent Litigation and Innovation Act of 2013 (entire bill) H.R. 2466, Private Right of Action Against Theft of Trade Secrets Act of 2013 (entire bill)

Client expense: $20,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

H.R. 22, Foreign Counterfeit Merchandise Prevention Act: Provisions related to counterfeiting H.R. 845, Saving High-Tech Innovators from Egregious Legal Disputes Act of 2013 (the SHIELD Act): Provisions related to patent litigation H.R. 2024, End Anonymous Patents Act: Patent owner information provisionsH.R. 2582, PATENT Jobs Act: Provisions related to patent user fees H.R. 2605, Manufacturing Innovation in America Act of 2013: Provisions related to patent tax boxes H.R. 2639, Patent Litigation and Innovation Act: Patent litigation proposals H.R. 2766, STOP Act: Provisions related to business method patents H.R. 2985: Combination Drug Development Incentive Act of 2013: Provisions related to drug exclusivity H.R. 3116, Moddern Cures Act of 2013: Provisions related to drug exclusivity S. 214, Preserve Access to Affordable Generics Act: Provisions related to patent settlements S. 504, Fair and Immediate Release of Generic Drugs Act: Provisions related to patent settlements S. 626, Prize Fund for HIV/AIDS Act: Medical prize provisions S. 627, Medical Innovation Prize Fund Act: Medical prize provisions S. 712, Patents for Humanity Program Improvement Act of 2013: Transferability of PTO vouchers provisions S. 866, Patent Quality Improvement Act of 2013: Business methods patents provisions S. 1013, Patent Abuse Reduction Act of 2013: Patent litigation provisions Biopharmaceutical innovation policy issues Potential legislation regarding patent litigation issues America Invents Act issues including estoppel for post grant review Biologics data protection issues

Client expense: $4,020,000 · Firm income: Not reported

- HR 22 Foreign Counterfeit Merchandise Prevention Act all provisions relating to cable. - HR 96 Cameras in the Courtroom Act all provisions relating to cable. - HR 128 Fairness in Political Advertising Act of 2013" all provisions relating to cable.- HR 148 Disclosure of Information on Spending on Campaigns Leads to Open and Secure Elections (DISCLOSE) 2013 Act all provisions relating to cable. - HR 504 To save at least $10,000,000,000 by consolidating some duplicative and overlapping Government programs all provisions relating to cable. - HR 539 Federal Communications Commission Collaboration Act of 2013 all provisions relating to cable. - HR 778 No Stolen Trademarks Honored in America Act all provisions relating to cable. - HR 845 Saving High-Tech Innovators from Egregious Legal Disputes Act of 2013 all provisions relating to cable. - HR 917 Sunshine in the Courtroom Act of 2013- to provide media coverage of federal court proceedings all provisions relating to cable. - HR 1565 Public Safety and Second Amendment Rights Protection Act of 2013 all provisions relating to cable. - HR 1572 To prohibit the use of Federal money for print, radio, television or other media advertisement, campaign, or form of publicity against the use of food or beverage that is lawfully marketed under the Food, Drug, and Cosmetic Act all provisions relating to cable. - HR 1605 Public Safety and Second Amendment Rights Protection Act of 2013 all provisions relating to cable. - HR 1734 Shareholder Protection Act of 2013 all provisions relating to cable. - HR 1831 Read the Bills Act all provisions relating to cable. - HR 1954 Sunset Wasteful Executive Expenditures and Programs Act of 2013 all provisions relating to cable. - HR 1962 The Free Flow of Information Act of 2013 all provisions relating to cable. - HR 2024 End Anonymous Patents Act all provisions relating to cable. - HR 2236 Promoting Startup Innovation Act all provisions relating to cable. - HR 2342 Federal Agriculture Reform and Risk Management Act of 2013 all provisions relating to cable. - HR 2356 We Are Watching You Act of 2013 all provisions relating to cable. - HR 2466 Private Right of Action Against Theft of Trade Secrets Act of 2013 all provisions relating to cable. - HR 2639 Patent Litigation and Innovation Act of 2013 all provisions relating to cable. - HR 2649 FCC ABCs Act of 2013, to reform the FCCs process during rulemaking all provisions relating to cable. - HR 2670 OPEN Act, to require corporations and labor unions to disclose to their shareholders or members the amounts disbursed for certain political activity all provisions relating to cable. - HR 2739 Efficient Use of Government Spectrum Act all provisions relating to cable. - HR 2766 STOP (Stopping the Offensive Use of Patents) Act all provisions relating to cable. - HR 2786 Financial Services and General Government Appropriations Act of 2014 all provisions relating to cable. - HR 2787 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2014 all provisions relating to cable. - HR 2844 Federal Communications Commission Consolidated Reporting Act of 2013 all provisions relating to cable. - HR 2911 Wireless Microphone Users Interference Protection Act of 2013 all provisions relating to cable. - HR 3196 To amend the Communications Act of 1934 to prohibit the Federal Communications Commission from adopting certain rules or policies relating to multichannel video programming distributors all provisions relating to cable. - HR 3219 To amend title 17, United States Code, to provide copyright owners in sounds recordings with the exclusive right to negotiate in the marketplace the performance of their works to the public by means of an audio transmission all provisions relating to cable. - HCon, Res. 16 Supporting the Local Radio Freedom Act- all provisions relating to cable. - HJRes 59 Continuing Appropriations Resolution, 2014 all provisions relating to cable. - HRes 174 Expressing the sense of the House of Representatives that the Speaker should immediately request a conference and appoint conferees to complete work on a fiscal year 2014 budget resolution with the Senate all provisions relating to cable. - S 2 Sandy Hook Elementary School Violence Reduction Act all provisions relating to cable. - S 134 Violent Content Research Act of 2013 all provisions relating to cable. - S 245 Federal Communications Commission Collaboration Act of 2013 all provisions relating to cable. - S 649 Safe Communities, Safe Schools Act of 2013 all provisions relating to cable. - S 405 Sunshine in the Courtroom Act of 2013-to provide media coverage of federal court proceedings all provisions relating to cable. - S 712 Patents for Humanity Program Improvement Act of 2013 all provisions relating to cable. - S 791 Follow the Money Act of 2013 all provisions relating to cable. - S 807 Plain Writing Act for Regulations of 2013 all provisions relating to cable.- S 824 Shareholder Protection Act of 2013 all provisions relating to cable. - S 866 Patent Quality Improvement Act of 2013 all provisions relating to cable. - S 912 Television Consumer Freedom Act of 2013 all provisions relating to cable. - S 987 Free Flow of Information Act all provisions relating to cable. - S 1013 Patent Abuse Reduction Act of 2013 all provisions relating to cable. - S 1173 Independent Agency Regulatory Analysis Act of 2013 all provisions relating to cable. - S 1207 Cameras in the Courtroom Act all provisions relating to cable. - S 1245 Energy and Water Development and Related Agencies Appropriations Act, 2014 all provisions relating to cable. - S 1379 Federal Communications Commission Consolidated Reporting Act of 2013 all provisions relating to cable. - S 1524 PRO Sports Act all provisions relating to cable. - S Res 110 Preventing Duplicative and Overlapping Government Programs Resolution all provisions relating to cable.

H.R. 22 - Foreign Counterfeit Merchandise Prevention Act H.R. 845 - Saving High-Tech Innovators from Egregious Legal Disputes Act H.R. 2024 End Anonymous Patents Act H.R. 2466 Private Right of Action Against Theft of Trade Secrets ActH.R. 2582 Patents and Trademarks Encourage New Technology Jobs Act H.R. 2639 Patent Litigation and Innovation Act H.R. 2766 Stopping Offensive Use of Patents Act H.R. ____ 1st and 2nd Abusive Patent Litigation Discussion Draft S. 214 - Preserve Access to Affordable Generics Act S. 504 The Fair and Immediate Release of Generic Drugs Act S. 660 Innovation Through Trade Act S. 662 - Trade Facilitation and Trade Enforcement Reauthorization Act S. 712 Patents for Humanity Program Improvement Act of 2013 S. 866 Patent Quality Improvement Act S. 1013 Patent Abuse Reduction Act S. ____ Whitehouse Discussion Draft to ensure greater protections for trade secrets

Client expense: $80,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

H.R. 22, Foreign Counterfeit Merchandise Prevention Act (entire bill) H.R. 845, Saving High-Tech Innovators from Egregious Legal Disputes (SHIELD) Act (entire bill) H.R. 1663, Promoting Automotive Repair. Trade and Sales (PARTS) Act (entire bill) S. 780, Promoting Automotive Repair. Trade and Sales (PARTS) Act (entire bill)H.R. 2024, the End Anonymous Patents Act (entire bill) H.R. 2236, the Promoting Startup Innovation Act (entire bill) H.R. 2582, the PATENT Jobs Act (entire bill) S. 214, Prohibiting the delay of generic drugs into the market (entire bill) S. 662, Trade Facilitation and Trade Enforcement Reauthorization Act of 2013 (IP-related provisions) S. 866, To Make Improvements to Transitional Program for Covered Business Method Patents (entire bill) S. 1013 Patent Abuse Reduction Act of 2013 (entire bill). S. 712, Patents for Humanity Program Improvement Act of 2013 (entire bill) Issues related to possible trade secret legislation Issues related to USPTO funding and sequestration

Client expense: $20,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

H.R. 22, Foreign Counterfeit Merchandise Prevention Act: Provisions related to counterfeiting H.R. 845, Saving High-Tech Innovators from Egregious Legal Disputes Act of 2013 (the SHIELD Act): Provisions related to patent litigation H.R. 2024, End Anonymous Patents Act: Patent owner information provisionsH.R. 2582, PATENT Jobs Act: Provisions related to patent user fees H.R. 2605, Manufacturing Innovation in America Act of 2013: Provisions related to patent tax boxes S. 214, Preserve Access to Affordable Generics Act: Provisions related to patent settlements S. 504, Fair and Immediate Release of Generic Drugs Act: Provisions related to patent settlements S. 626, Prize Fund for HIV/AIDS Act: Medical prize provisions S. 627, Medical Innovation Prize Fund Act: Medical prize provisions S. 712, Patents for Humanity Program Improvement Act of 2013: Transferability of PTO vouchers provisions S. 866, Patent Quality Improvement Act of 2013: Business methods patents provisions S. 1013, Patent Abuse Reduction Act of 2013: Patent litigation provisions Biopharmaceutical innovation policy issues Potential legislation regarding patent litigation issues America Invents Act issues including estoppel for post grant review Biologics data protection issues Counterfeit drug issues Premerger Notification; Reporting and Waiting Period Requirements; Notice of proposed rulemaking (77 Federal Register 50057)

Client expense: $4,400,000 · Firm income: Not reported

H.R. 22 - Foreign Counterfeit Merchandise Prevention Act H.R. 845 - Saving High-Tech Innovators from Egregious Legal Disputes Act H.R. 1663 Promoting Automotive Repair, Trade, and Sales Act H.R. 2024 End Anonymous Patents ActH.R. ____ Abusive Patent Litigation Discussion Draft H.R. 2236 Promoting Startup Innovation Act A bill to amend title 35, United States Code, to modify the definition of micro entity. H.R. 2466 Private Right of Action Against Theft of Trade Secrets Act H.R. 2582 Patents and Trademarks Encourage New Technology Jobs Act S. 214 - Preserve Access to Affordable Generics Act S. 504 The Fair and Immediate Release of Generic Drugs Act S. 660 Innovation Through Trade Act S. 662 - Trade Facilitation and Trade Enforcement Reauthorization Act S. 712 Patents for Humanity Program Improvement Act of 2013 S. 780 PARTS Act S. 866 Patent Quality Improvement Act S. 884 Deter Cyber Theft Act S. 1013 Patent Abuse Reduction Act

Client expense: $80,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)